NPPA Fixed Retail Price of 25 Formulations - Summary
The National Pharmaceutical Pricing Authority (NPPA) is responsible for fixing and regulating the prices of medicines in India. The organization regularly releases a price list that contains information about the maximum retail price (MRP) of various pharmaceutical products, including essential medicines and medical devices. The latest NPPA price list for 2025 is now available, and it has important implications for consumers and healthcare providers across the country.
NPPA Fixed Retail Price of 25 Formulations
The NPPA price list for 2025 contains details about the maximum retail prices of various pharmaceutical products, including drugs and medical devices. The list is updated regularly to ensure that the prices of essential medicines and medical devices remain affordable and accessible to the general public. This year’s list is particularly important, as it includes several new drugs and medical devices that have been approved by the regulatory authorities.
The NPPA price list for 2025 is an important resource for healthcare providers and patients alike. It provides information about the maximum retail prices of essential medicines and medical devices, which can help consumers make informed decisions about their healthcare. By knowing the prices of various drugs and medical devices, consumers can choose the most affordable and effective options for their health needs.
If you’re a healthcare provider, the NPPA price list for 2025 can help you make informed decisions about prescribing medicines and medical devices. By knowing the prices of various drugs and devices, you can choose the most affordable and effective options for your patients.
The NPPA price list for 2025 is an important resource for anyone who needs to purchase essential medicines or medical devices. It provides information about the maximum retail prices of various products, which can help consumers make informed decisions about their healthcare. If you’re a healthcare provider or a consumer, make sure to consult the latest NPPA price list before making any healthcare-related purchases.
NPPA of New Retail Price of 25 Formulations
| Name of the Formulation / Brand Name | Manufacturer Company | Retail Price (Rs.) |
|---|---|---|
| Itraconazole Capsules (Supra- Bioavailable Formulation) | M/s Ravenbhel Healthcare Pvt. Ltd. | 20.72 |
| Telmisartan & Chlorthalidone Tablets | M/s Innova Captab Limied | 8.04 |
| Camylofin Dihydrochlorid e and Paracetamol Tablets | M/s Pure and Cure Healthcare Pvt. Ltd. | 5.53 |
| Glimepiride tablets IP | M/s Skymap Pharmaceuticals Pvt. Ltd. | 11.57 |
| Glimepiride tablets IP | M/s Skymap Pharmaceuticals Pvt. Ltd. | 9.77 |
| Gliclazide (MR) and Metformin Hydrochloride (ER) Tablets | M/s Swiss Garniers Genexiaa Sciences Pvt. Ltd. | 6.57 |
| Bilastine and Montelukast Orodispersible Tablets | M/s Akums Drugs & Pharmaceuticals Ltd. | 13.21 |
| Chlorpheniram ine Maleate and Phenylephrine Hydrochloride Syrup | M/s Stedman Pharmaceuticals Pvt. Ltd. | 1.16 |
| Dapagliflozin & Metformin Hydrochloride (Extended Release) Tablets | M/s Synokem Pharmaceuticals Ltd. | 7.31 |
| Dapagliflozin & Metformin Hydrochloride (Extended Release) Tablets | M/s Synokem Pharmaceuticals Ltd. | 10.53 |
| Dapagliflozin & Metformin Hydrochloride (Extended Release) Tablets | M/s Synokem Pharmaceuticals Ltd. | 9.1 |
| Dapagliflozin & Metformin Hydrochloride (Extended Release) Tablets | M/s Synokem Pharmaceuticals Ltd. | 9.1 |
| Dapagliflozin & Metformin Hydrochloride (Extended Release) Tablets | M/s Synokem Pharmaceuticals Ltd. | 10.53 |
| Levocetirizine, Montelukast & (SR) Ambroxol Hydrochloride Tablets | M/s Akums Drugs & Pharmaceuticals Ltd. | 15.39 |
| Omeprazole & Domperidone Capsules IP | M/s Innova Captab Ltd. | 5.9 |
| Combi pack of Clarithromycin Tablets IP, Esomeprazole Tablets IP & Amoxicillin Tablets USP | M/s Malik Lifesciences Pvt. Ltd. | 152.17 |
| Bisoprolol Fumarate & Amlodipine Besylate tablets | M/s Tha Madras Pharmaceuticals | 8.34 |
| Bisoprolol Fumarate & Amlodipine Besylate tablets | M/s Tha Madras Pharmaceuticals | 6.19 |
| Erythropoietin Injection BP 6000 IU/ml | M/s Gennova Biopharmaceutica ls Ltd. | 1449.74 |
| Glycopyrroniu m Ph. Eur, Formoterol Fumarate IP and Budesonide Inhalation powder | M/s Lupin Limited | 12.19 |
| Bisoprolol Fumarate & Amlodipine Tablets | M/s J. K. Printpack | 8.34 |
| Cilnidipine & Telmisartan Tablets | M/s Akums Drugs & Pharmaceuticals Ltd. | 12.83 |
| Ceftazidime and Avibactam powder for concentrate for solution for infusion | M/s BDR Pharmaceuticals International Pvt. Ltd. | 3773.31 |
| Cilnidipine, Telmisartan & Chlorthalidone Tablets | M/s Pure and Cure Healthcare Pvt. Ltd. | 13.17 |
| ORS with Zinc powder 4.38g | M/s FDC Limited | 6.12 |
You can download the NPPA price list 2025 PDF in high-quality and printable format by using the link given below.